PESTEL surfaces the forces reshaping healthcare. The hard part is next: putting an owner on every objective it creates. Here's how to close the gap.
Key Takeaways
  • Keep only the forces that would change a decision. Score each of the six on impact and likelihood, using regulation trackers, payer news and frontline staff.
  • Convert each high-impact force into a dated objective. "Telehealth reimbursement is shrinking" becomes "protect virtual-care margin by Q3"; an unconverted force is just anxiety.
  • Put a name on every objective. Initiatives with a named owner complete at 2.5x the rate (21.5% versus 8.7%) in ClearPoint data, and ClearPoint shows which healthcare objectives still need an owner.
  • Wire each objective to a measure and a recurring review date. In healthcare, owned objectives reach on-track more often (24% versus 19%); pair ownership with regular review.
  • Feed the findings into your SWOT next. Where PESTEL fits with the rest of your plan shows how survivors become owned, measured objectives.
Google AI answers

Get our answers first in Google.

Add ClearPoint as a preferred source →

A hospital CFO can name every force bearing down on her system: the reimbursement squeeze, the nursing shortage, the AI vendor knocking weekly. She runs the PESTEL analysis, fills the six boxes, and presents it to the board. Then the quarter starts, and nobody opens the slide again.

A PESTEL analysis in healthcare scans the six external forces that shape a healthcare organization (Political, Economic, Social, Technological, Environmental, and Legal) so strategy can move before those forces force the decision. In healthcare, the scan is rarely the problem. The problem is what happens to it next.

We can see the follow-through, objective by objective. For the 6,282 strategic objectives that 50 health systems set on the ClearPoint platform, ClearPoint shows which still need an owner and which haven't had a status update yet. The analysis is the easy half. The follow-through decides the outcome. This guide covers both: the six forces with current 2026 examples, then the follow-through.

The 6 PESTEL forces in healthcare (2026)

Each force is one of the external factors pressing on your organization, and each is already asking you a question. PEST stops at the first four; healthcare needs all six, because it's governed by Legal forces and increasingly by Environmental ones.

Force 2026 signal in healthcare The question it forces
PoliticalEnhanced premium tax-credit expiry, Medicare/Medicaid policy, telehealth reimbursementWho pays you, and when?
EconomicLabor inflation, reimbursement lagging costs, deferred elective careWhich revenue survives a downturn?
SocialAging, chronically ill population; digital-front-door expectations; clinician burnoutDoes your care model fit tomorrow's patients?
TechnologicalClinical AI, ambient documentation, telemedicine, interoperability, cybersecurityWhat redefines your standard of care?
EnvironmentalClimate resilience for facilities, medical-waste rules, supply-chain decarbonizationCan you run through a climate event?
LegalHIPAA, accreditation, malpractice, AI governance — Texas's TRAIGA took effect Jan 1, 2026What becomes non-negotiable?

That table is the easy half. The other half is what we can see from inside the platform.

The follow-through: owners, measures, review dates

A PESTEL scan produces strategic objectives: "shift to value-based care," "stand up an AI governance committee," "harden three facilities for climate risk." Each one needs an owner, a measure, and a review date. ClearPoint shows which ones still lack an owner.

Across the sectors we track, initiatives with a named owner complete at 2.5x the rate (21.5% vs 8.7%), and ClearPoint shows healthcare teams which objectives still need an owner. An objective with no owner is a sentence in a slide deck. It is not a plan.

That includes the objectives healthcare is most excited about. Group those 6,282 objectives by what their titles are about, and ClearPoint shows which themes (AI, telehealth, EHR, digital) still need a named owner.

Technology-themed healthcare objectives: ClearPoint flags which still need an owner, as it does for every healthcare objective. (Classifying the 6,282 objectives by the words in their titles; 543 land on technology.)

ClearPoint shows when each one was last scored and keeps that review history on every objective.

How often owned objectives reach on-track
ClearPoint platform · 6,282 healthcare objectives, 50,524 platform-wide · June 2026
Platform-wide, owned
46%
Platform-wide, unowned
22%
Healthcare, owned
24%
Healthcare, unowned
19%
Owned objectives reach on-track more often in both views

This isn't abstract. Real objectives in these plans read "Improve and Expand Access to Care" and "Improve the patient experience through enhancing healthcare navigation." ClearPoint shows whether each one has an owner and a status.

Share of objectives ever marked "on track"
ClearPoint platform · owned vs unowned · June 2026
46%
22%
Across the platform (~2×)
24%
19%
Healthcare (~1.3×)
Orange = owned · Blue = no owner

This part surprised us. Across the whole platform, giving an objective an owner roughly doubles its odds of ever going green: 46% owned versus 22% unowned. In healthcare the gap is smaller, 24% versus 19%, and owned objectives are measured 33% of the time against 57% platform-wide. Ownership pays off when it's wired to a review cadence.

You may have heard that "70% of strategies fail." That figure has no credible source. It's been repeated since the 1980s without one. Here are numbers with a source: across ClearPoint's platform, owned objectives reach on-track 46% vs 22% for unowned ones. The forces were never the problem. The silence after the scan is.

How to run a PESTEL analysis in healthcare that survives the meeting

  1. List the forces that actually move you. Use the six above; pull signals from regulation trackers, payer announcements, and your own frontline staff. Score each on impact and likelihood, and keep the few that would change a decision.
  2. Convert each high-impact force into an objective. "Telehealth reimbursement is shrinking" becomes "protect virtual-care margin by Q3." A force you don't convert is just anxiety.
  3. Put a name on every objective. An unowned objective is no one's job by Monday.
  4. Wire each one to a measure and a recurring review date. An objective nobody revisits is a wish, not a plan.

Where PESTEL fits with the rest of your plan

PESTEL maps the forces you don't control; a SWOT analysis weighs them against the strengths and weaknesses you do. Run PESTEL first, pour its findings into the opportunities and threats of your SWOT, and carry the survivors into your healthcare strategic plan as owned, measured objectives rather than bullet points.

From scan to living plan

A PESTEL analysis tells you what's coming. It doesn't make anyone act on it. Closing the gap between the scan and the follow-through is the whole job of strategy execution, and it's why ClearPoint exists. Every objective gets an owner, a measure, and a cadence; the ones that drift turn red before the board meeting, not after.

The health systems already running their plans this way don't talk about prettier reports. They talk about the loop. When the American Association of Critical-Care Nurses moved its plan into ClearPoint, its business strategy specialist put it this way:

"We were able to realign our planned work to our desired results and create new custom reports to help us see the impact of our efforts on our nursing community."
— Tracey Birosak, Business Strategy Specialist, American Association of Critical-Care Nurses

Cancer centers, trauma hospitals, and health departments run on the same loop, including Carilion Clinic and San Juan Regional Medical Center.

Go back to the CFO. She has the same six forces and the same board slide. The analysis is no sharper. The difference is that each objective now carries a name, a number, and a review date. The virtual-care-margin objective turns yellow in week six, not at year-end. The job is to stay awake to the future, not to predict it.

A PESTEL analysis is a list of promises the outside world is about to test. In healthcare, the median promise is never checked again.

Common questions

What is the difference between PEST and PESTEL analysis?

PEST covers four forces — Political, Economic, Social, and Technological. PESTEL adds Environmental and Legal. In healthcare those two are decisive: the sector is shaped heavily by regulation (Legal) and increasingly by climate resilience and waste rules (Environmental), so PESTEL is the more complete fit.

What are examples of PESTEL factors in healthcare in 2026?

Political: premium tax-credit expiry and telehealth reimbursement. Economic: labor inflation and deferred elective care. Social: an aging, chronically ill population and clinician burnout. Technological: clinical AI, telemedicine, and cybersecurity. Environmental: climate resilience and medical-waste rules. Legal: HIPAA, accreditation, and new AI governance laws such as Texas's TRAIGA, effective January 1, 2026.

What should you do after completing a PESTEL analysis?

Convert each high-impact force into a strategic objective, then give every objective an owner, a measure, and a review date. This last step is the one that pays off: in ClearPoint data, initiatives with a named owner complete at 2.5x the rate (21.5% vs. 8.7%), and ClearPoint shows healthcare teams which objectives still need an owner or a status update.

How often should a healthcare organization update its PESTEL analysis?

Review it at least annually, and again whenever a major external force shifts — a new reimbursement rule, an AI regulation, a merger, or a climate event affecting facilities. The bigger discipline is reviewing the objectives it produced on a fixed cadence; on our platform, the objectives that get reviewed more than once are the rare ones that ever reach on-track.

Is PESTEL or SWOT better for healthcare strategy?

They do different jobs, so use both. PESTEL maps the external forces you don't control; SWOT weighs those forces against your internal strengths and weaknesses. Run PESTEL first and feed its findings into the Opportunities and Threats of your SWOT.

Ted Jackson
Ted Jackson
Co-Founder & Alabama Native

Co-Founder and Managing Partner of ClearPoint. Former VP at Kaplan and Norton's Balanced Scorecard Collaborative.

Ted Jackson is the co-founder of ClearPoint Strategy, a B2B SaaS platform that empowers organizations to execute strategic plans with precision. Before ClearPoint, he was Vice President at the Balanced Scorecard Collaborative — later the Palladium Group — the firm Drs. Robert Kaplan and David Norton founded to put their framework into practice, where he led global sales and support for its strategy management software and wrote three articles for the Balanced Scorecard Report. A Duke and Harvard Business School alumnus, he brings over 30 years' experience in strategy execution, including 15 years implementing the Balanced Scorecard in the field. Ted works closely with customers to ensure the software meets unique challenges, continually refining the platform with his global expertise.